search
ONGC
Trends
- 1Long Covid autoantibody study finds no single immune signature▼Some autoantibodies against neuronal targets found in people with # LongCovid but no specific signature....it's heteroge
New findings show that some people with Long Covid carry autoantibodies targeting neuronal cells, but no consistent antibody signature has been identified across patients. Commenters say the picture is heterogeneous, meaning the immune response differs from person to person. Many note this fits expectations that Long Covid and ME/CFS have an autoimmune component without being classic autoimmune diseases like multiple sclerosis.
- 2Fourth COVID vaccine dose cuts long COVID risk by a third●Study Finds Fourth COVID-19 Vaccine Dose Cuts Long COVID Risk by Nearly a Third # COVID # LongCovid # vaccines https://
A new study reports that a fourth dose of the COVID-19 vaccine reduces the risk of developing long COVID by nearly a third in previously vaccinated or immune people. The findings add to ongoing debate about booster schedules and the lasting benefits of vaccination beyond preventing severe illness, with health watchers weighing what it means for future booster recommendations.
- 3Leopoldina calls for better Long COVID therapies affecting 1.5 million●1,5 Mio. Betroffene: Leopoldina fordert bessere Therapien bei # LongCOVID Ich fordere Prävention, denn COVID und Long CO
The German National Academy of Sciences Leopoldina is urging improved therapies for Long COVID, a condition affecting an estimated 1.5 million people in Germany. Commenters support the call but stress prevention, arguing COVID and Long COVID are not over and criticizing the vaccination commission STIKO for recommending booster shots only for a limited group of people.